In a recent study published in the journal Nature Medicine, an international team of researchers evaluated the efficacy, safety, and tolerability of extended-release ketamine tablets (R-107) in adult ...
BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has approved ...
Credit: FDA. The letter states that the application cannot be approved in its present form. The Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) to Incyte regarding the ...
Pfizer Inc. announced today that the U.S. Food and Drug Administration has approved XELJANZ ® XR extended-release 11 mg and 22 mg tablets for the once-daily treatment of adult patients with moderately ...
October 7, 2010 — The US Food and Drug Administration (FDA) has approved clonidine hydrochloride, 0.1-mg and 0.2-mg, extended-release tablets (Kapvay; Shionogi Inc ...
1 st and only once-daily combination containing the active ingredient of TOPROL-XL ® (metoprolol succinate) ER tablets plus low-dose hydrochlorothiazide, offers the dual efficacy of a beta blocker and ...
AHMEDABAD, India--(BUSINESS WIRE)--Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as “Zydus”) announces the launch of ...
Granules India Ltd on Thursday said its arm Granules Pharmaceuticals, Inc has received tentative approval from the US health regulator for its generic amphetamine extended-release tablets indicated ...
Nostrum Laboratories has voluntarily recalled another lot of metformin HCl extended-release tablets 750 mg dosage, expanding their initial announcement in November 2020. According to the new notice, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results